Pre-order Enquiry
Download Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
2,4-Thiazolidinedione (CAS 2295-31-0) is a white to off-white crystalline powder with the molecular formula C3H3NO2S. It is mainly used as an intermediate for thiazole sensitizers such as Troglitazone, Piglitazone and Rosiglitazone.
According to Researcher's new survey, global 2,4-Thiazolidinedione market is projected to reach US$ 22 million in 2029, increasing from US$ 16 million in 2022, with the CAGR of 4.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole 2,4-Thiazolidinedione market research.
Key manufacturers engaged in the 2,4-Thiazolidinedione industry include Sarex, Robinson Brothers, Hangzhou Ribo Pharmaceutical Science & Technology, Jinan Shengqi Pharmaceutical and Dezhou Haizhi Pharma, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
For production bases, global 2,4-Thiazolidinedione production is dominated by and . The two regions contributed to % production share globally in 2022.
When refers to consumption region, % volume of 2,4-Thiazolidinedione were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole 2,4-Thiazolidinedione market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global 2,4-Thiazolidinedione market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Sarex
Robinson Brothers
Hangzhou Ribo Pharmaceutical Science & Technology
Jinan Shengqi Pharmaceutical
Dezhou Haizhi Pharma
Segment by Type
Purity above 98%
Purity above 99%
Others
Segment by Application
Pioglitazone Intermediate
Rosiglitazone Intermediate
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
The 2,4-Thiazolidinedione report covers below items:
Chapter 1: Product Basic Information (Definition, type and application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source
According to Researcher's new survey, global 2,4-Thiazolidinedione market is projected to reach US$ 22 million in 2029, increasing from US$ 16 million in 2022, with the CAGR of 4.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole 2,4-Thiazolidinedione market research.
Key manufacturers engaged in the 2,4-Thiazolidinedione industry include Sarex, Robinson Brothers, Hangzhou Ribo Pharmaceutical Science & Technology, Jinan Shengqi Pharmaceutical and Dezhou Haizhi Pharma, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
For production bases, global 2,4-Thiazolidinedione production is dominated by and . The two regions contributed to % production share globally in 2022.
When refers to consumption region, % volume of 2,4-Thiazolidinedione were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole 2,4-Thiazolidinedione market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global 2,4-Thiazolidinedione market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Sarex
Robinson Brothers
Hangzhou Ribo Pharmaceutical Science & Technology
Jinan Shengqi Pharmaceutical
Dezhou Haizhi Pharma
Segment by Type
Purity above 98%
Purity above 99%
Others
Segment by Application
Pioglitazone Intermediate
Rosiglitazone Intermediate
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
The 2,4-Thiazolidinedione report covers below items:
Chapter 1: Product Basic Information (Definition, type and application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source
Frequently Asked Questions
This market study covers the global and regional market with an
in-depth analysis of the
overall growth prospects...
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by
highlighting information on
different aspects including drivers, restraints...
